Methionine oxidation contributes to bacterial killing by the myeloperoxidase system of neutrophils

Henry Rosen1, Seymour J Klebanoff, Yi Wang

  • 1Department of Medicine, University of Washington, Seattle, WA 98195, USA. hqr@u.washington.edu

Insights

Neutrophils use myeloperoxidase (MPO) to oxidize bacterial methionine, a key step in killing pathogens. This methionine oxidation damages essential bacterial proteins, contributing to neutrophil-mediated bacterial clearance.

Area of Science:

  • Microbiology
  • Immunology
  • Biochemistry

Background:

  • Neutrophils generate reactive oxygen intermediates crucial for bacterial killing and inflammatory processes.
  • The precise molecular targets of neutrophil-mediated bacterial damage remain largely undefined.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which neutrophils kill bacteria, focusing on the role of myeloperoxidase (MPO).
  • To identify specific bacterial targets damaged by MPO-derived oxidants.

Main Methods:

  • Investigated the conversion of methionine residues to methionine sulfoxide in Escherichia coli by neutrophils.
  • Utilized neutrophils deficient in MPO system components (MPO, H2O2, chloride) to assess bactericidal activity.
  • Examined the effects of hypochlorous acid (HOCl) on bacterial proteins and viability.
  • Assessed the impact of bacterial methionine sulfoxide repair systems on susceptibility to HOCl.

Main Results:

  • Neutrophils efficiently convert bacterial methionine to methionine sulfoxide via the MPO system.
  • MPO-deficient neutrophils showed reduced bactericidal activity and methionine oxidation.
  • HOCl, the MPO product, directly correlates microbicidal activity with methionine oxidation in bacterial proteins.
  • Bacterial methionine sulfoxide repair systems modulate susceptibility to HOCl-induced killing.
  • Oxidation of proteins involved in peptide synthesis and translocation to the cell envelope was prominent.

Conclusions:

  • MPO-mediated methionine oxidation is a significant contributor to neutrophil-induced bacterial killing.
  • Damage to proteins involved in cell envelope protein translocation is a critical pathway targeted by neutrophils.

Related Concept Videos

Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Microbes and Other Elemental Cycles01:24

Microbes and Other Elemental Cycles

Microbial activity plays a pivotal role in the biogeochemical cycling of iron and manganese, especially at the redox gradients characteristic of stratified aquatic environments. These cycles are driven by microbial transformations between oxidized and reduced forms of the metals, allowing organisms to exploit them for metabolic energy and structural purposes.Iron Cycling Across Redox GradientsIn neutral, oxygen-rich surface waters, iron is predominantly found in its oxidized, insoluble ferric...